QQ : QQ 17 Q 8 Q 11 Q , Q Q, QQ QQ, QQ lupus erythematosus, LE

QQ : QQ 17 Q 8 Q 11 Q , Q Q, QQ QQ, QQ lupus erythematosus, LE

357
Vol. 33, pp. 357ῒ363, 2005
῎ : 17 8 11 ῏
8 2 '’OV,“85Ž+=’
b-?
ῌ '[N,8 1 -
# $%&'()*+(,
ῌlupus erythematosus, LE῍ -
!"
c 8=+ctt
”VR,8(6•,.N5(
. 11῍ '/
῍ LE 0
12340567 discoid lupus erythematosus ῌDLE῍ 8 9*':0,;<8=+- sys-
P$I- LE -
8=+ !F–-
V
temic lupus erythematosus ῌSLE῍ >?@A-B
R,
—˜&5P-. 21῏ '/0
bbQcK™
C8=+-DE1!F ῌsubacute cutaneous lu-
&!F†4VE1 ῌacute cutaneous LE, ACLE῍
pus erythematosus, SCLE῍ - 3 .G8= (H
DE1 ῌsubacute cutaneous LE, SCLE῍ 1
IJ-KL.MNOP-QR,
$ST&5
ῌchronic cutaneous LE, CCLE῍ - 3 I'
'UN,V WX-YZ.[N*\]^='
9*)V!"'?‚n)'š
H(_
85Ž+(,
b-
V`,
›œc
–
-QR,V RH’QP!"-
1῏ SLE aA'234!"VU)*,b8cdQc
n*
n*, 8(“
J‚t0(P
QR‚ 1 -
5 H SLE a A - 2 3 4 ! " 8 e SLE a A -
DLE 8-C'f& gh&5i(cS(jk
(¡c 1 2 -¢'U)*+>‚ b-˜
5(
j£.S+(O-Qc SCLE 8cQR,-J
2῏ SCLE 8lmn*OaA-oHV SLE -lmp
!"QR,-J
q.r0,
8-žVŸ 8=5(
K' SCLE 8
J)5H5,
῎ DLE 3῏ s
LE tuv1wxyz LE c SLE a
n)' LE -
A'U)*,b8Vo(
.
J‚'HH=+(,-c
4῏ { 1 LE ' c SLE - f . / 0 P - 8
DLE 8(¡-¤I¥V 9-()*,4
DLE -f./0P-VR,
¦'?‚QR,b8QR,
JI+!FV
8c0567|a-}~€QR‚
§8¨‡- LE aA.©Ž+(Oª—'c LE c
ƒ 9-„8lmn*O…-†V‡-
«¬'!F&5S­J) E1®¯4
'ˆ0,-J.‰Š,b8VQ‹,cŒ-P-QR
ῌ#- SLE῍ 81234
c95Ž+>)Œ 
ῌ(6°, DLE῍ 8'
±n*+(O
b-
'  ‘ O ?  5 † c SLE ῑ DLE SCLE ῑ
*J) DLE . SLE 8:²'R,1 !F
SLE s
LEῑSLE {1 LEῑDLE 5‡
- LE 8=+8)N,[N¢V³´&QR‚ N
,
=J= 1 -
\µ¶·
!F¸¹QR,#º»¼c DLE
. ῐ234-!".¤7 ;<†4.½65(P
!F
1
358
ῌ1
!"
ῌ1῍῍
ῌ2
ῌ1῍῍
2
YZ[\]^_`CMN
359
ῐ 2῏῍ DLE F= DLE $%!()z{W'&῎
῎ 1 N)k-|}W~
῍
!"#
$%&'῍ ($%)*%
ῌ +῎ SLE ),-!./ DLE 012
€<mnCMNN‚ƒ„…
3()῍
45῎ DLE '56786
†
‡$%ˆ‰!4῏῍ SLE 9:);%<=῎ >?@ABC
Š‹῎ NŒ‹
῎ '
D'῍ (( SLE ),
SpŽB"#'῎ 1῏῍ (=῎ 
-!./ DLE 0EF:4%3῏῍
);@"#῎‘x’
1 )G
HI)῎ JK LE LCM)N
“῎ DLE M῎ SCLE M”῏%῎ 5
F=HI)&῎ (O῎ LE SLE B•–G—
˜™š›œ4<῎
DLE )NPQRBSN
)TU
SLE 4῎ XžM CLE 4῎ VŸ ῍ V(῎ LE 9:WW
B4῎€< intermediate LE 0E
);XMYZ[\]^_` ῌcutaneous
῏¡!"#%I'῍
LE a! cutaneous-limited LE, CLE῍ IC
($%h„B῎ ¢£ LE CWH
W
<=(W'&῎ SLE );b
c
oF=i
¡!῍ m¤῎ 1 )GF
N4&
῍ 4dQRBSN)(e
=!"#):i¥
(
῍
f4῎ DLE ghij CLE k)
῍ l῍
mno
῎ JK DLE Icp
a῏ SLE
SLE "#5¦) American College of Rheu-
HI 3 q&O
<=῍
1῏ ./9r
matology "#§¨5῏6῏)§©ª=῍ X
"#῍
῎ «῎ ¬­῎ ®¯°±῎ ²°±῎
2῏ ./@῍
³´CwWµ'¶<=d&῎
3῏ rXM LE st῍
´·Cs„B)¸¹"#
x
(HIu῎ v!"#
¡῍ ºE"#§¨'a»$
' SLE CLE ῎ w)xyABD4<"#
'&῎ !%"#§¨!F SLE 1
YZ[\]^_`"#SpŽB$%῎€¼<4῏H&½
῏
3
¼89½
360
SLE '( 2 jkE!῍
῎ 1῏ lm: no῍
SLE m
!"#
!῍
b῏ Cutaneous-limited LE ῌCLE῍
!M
LE $%& ῌ'()*! ACLE,
#v
SCLE, CCLE῍ !῎ SLE +,-!%&.
!῎ 2a῏῍ !qemde^
!῎ ..$ei^῎ %ῌ.
wxyT:Zz!M
/0123῍ -45῎ .678
$^
9: ; < % & 2῎ = > ? @ A &O'῎ 2c῏῍
SLE +,-!3$B+C῍
2῏ €
c῏ Intermediate LE ῌILE῍
p!!qe
!῍ rstuM6῎ tue"
!῎ 2b῏῍ SLE !῎ {|}:~
‚(ƒem: }%„(ƒe
m…†῎ ‡ˆ:6)0E!῎ 3῏῍
C:DE῎ SLE ‰Š‹῎ *Œ+Ž&,
-!FE4!῎ G;<%&.=
e῎ …Ž!q‘’“”e•–—˜™῎ ‰
>H$B
Ššwx›œ]E!῍ žŸ ¡¢£¤ ¥
CLE I ILE J
K33L
!῍ M3%
¦3῎ *§¨
NDEOPQ-!῎ ILE 3RS
-©ª«¬­¢yT
]E῎ ®H¯῍
T῍ 3 ῐSLE Uῑ
b῏ Subacute cutaneous LE ῌSCLE῍
MV
1979 . Sontheimer _'/῎ p20F
V3D῍
1 DLE SLE W SCLE XD
!῎ SCLE ILE ;2$Y
E῎ °1T!῍ D῎
!
Sontheimer [\῎ SCLE ± ῐ2
῎ ZE῍ SCLE Sontheimer
²e³´῎ µ)¶3-hi LE
[\7῏] ῐ^ῑ _CM
^ῑ 3
ED῎`)῏῎ abA ῐ
ACLE ῎ $e²e·4`h¸-
ῑ c4!M῍
CCLE nW‚X-!C!7῏῍ -
45 SCLE ^_CM
E
ῌ D
a῏ Acute cutaneous LE ῌACLE῍
defgehi LE $^
a
2
῎ defgehi
!῍ SCLE 4!῎ 5¹,G
M.῎ HLA-DR3 76῎ º SS-A ºS7
!῍
b
c
a: rs2tulm῍ b: ..wxyT„lm῍ c: lm»{|}῍
4
±²³´µ¶·¸(G†
a
ῌ3
361
b
c
¯°±²³´µ¶·¸¹LM a: ºLM b, c: »¦ »¼LM
SCLE !"#$7῏8῏ %&'
SCLE ##
SCLE LE ()
*
SCLE '+ ,-./
0 SLE 12
!3#
# 4
567 SLE 8
4῏
9 : + " ; 5 # $ < - ( = > SCLE #?@A B
89C!
"$ :D+$EF
ῌ4
SCLE +
2 GHI! JKLM
JKLM½¯°±²³´µ¶·¸
G῎ῌ 4῏NῌG# OP#
1῏ DLE: Š‹ ƒ„LMŒ
JKLMGQR S!I#
# ŽŽ +Q‘’“
SLE 12TU""
”KŽ• –
—oz{ῌƒ˜
VWX# (YZ[#
\]^
z{]^LMŒ# ™š›
œLo
T_`aK= bc`defghij
ž›
Ÿor ῎ῌ 5῏ DLE kl YZmnopqr LE stu
ŒG¢£KG+†
vw DLE xy
z{>|#}
¤›¥›+¡Œ DLE Gh‘
z~
@5$ 4€klbc
Q‘¦ ¢£KG DLE §
`+E"@‚# #10῏
¥ › ¨ © DLE G Q ‘ #
9῏
c῏ Chronic cutaneous LE ῌCCLE῍
ƒ„ LE %…!+†
I+¡
! ¡ŒG DLE widespread DLE ª«!!+¬" h
! ‡
‘¡ŒG Q‘¢£KG@"†#
ˆ 3 ‰#
+­®
5
!"
š›œ
362
3῍ pqr
: stuv6w`a
b$<=pqxyz) {|"}` ~ €
`'ῌ 7῍ DLE 6!‚ƒ„…+
ῌ ACLE SLE "!†Nk3)Df ACLE $
‡ˆk? cutaneous-limited LE )D+=>
‰Šk+
CCLE 61‹ cutaneous-limited LE )D?
ŒŽr$<= SLE )D DLE "+
"‘‹GG ’“ƒ DLE )”…
a
b
5
6
7
pqr
c
•–r
a: ῌ b: —˜
c: —™
2῍ : DLE
!"ῌ#
$%&'() *+),-./ 0"1
+ 234567859) :
";$<
=>?1+ @ABC)D? E"FC?G
>HD IJKLMN"OPQRS
6TULV$W'? X 1 YZ,$[\'
]"V^_` ab cd`"ef78
TUL?ghijk7lmn$o'ῌ 6῍
6
Y3Z[\]^4´0Hµ$%
῍8
363
Y3Z[\]^4$%WX/²³
SLE \]^4yzª$%ª $hwx 1990;
32: 1139ῑ1149
!"# LE
$%
&'()*+, -./0
4῏
DLE 12 *
5῏ Tan EM, Cohen AS, Fries JF, Masi AT,
$%
&()
McShane DJ, Rothfield NF, Schaller JG, Talal
SLE 345678 -./0
N and Winchester RJ. The 1982 revised criteria
DLE &'()
for the classification of systemic lupus erythe-
!"# LE $%
&'
987 *:; SLE <67
matosus. Arthritis Rheum 1982; 25: 1271ῑ1277
4῏ =1 SLE ()1 DLE 0$%8>?@<
6῏ Hochberg MC. Updating the American Col-
Tan ?AB5῏ 177 C 31 ῎18ῐ῏
lage of Rheumatology revised criteria for the
classification of systemic lupus erythematosus.
SCLE SLE D? cutaneous-limited LE EF
Arthritis Rheum 1997; 40: 1725
G7HI JK
LM ῍ 8 NO1
7῏ Sontheimer RD, Thomas JR and Gilliam JN.
PQHD,R
῎
Subacute cutaneous lupus erythematosus. Arch
Dermatol 1979; 115: 1409ῑ1415
ῌ
8῏ Sontheimer RD, Maddison PJ, Reichlin M,
1῏ STUV WXY3Z[\]^4 _`ab
Jordan RE, Stastny P and Gilliam JN. Sero-
cde fg$hijkl 9 m Cnop
logic and HLA associations in subacute cuta-
qr 2002: 40ῑ60
neous lupus erythematosus, a clinical subset of
2῏ stuv DLE wxyzῌ{|yz }
lupus erythematosus. Ann Intern Med 1982; 97:
~€‚ $hi MOOK 7 Y3Z[\]
664ῑ671
^4wx ƒ„…† qr 1986: 139ῑ149
9῏ «Š¬› «­®¯ °±$hY3Z[\]
3῏ S‡ˆ‰ nŠ‹Œ Ž/Y3Z[\]^
^4 ῌAnnular-Polycyclic 0῍ 1 $hw
4 nt?‚ ‘’$hijkl 18
x 1998; 40: 2103ῑ2106
m Cnop qr 1984: 18ῑ28
10῏ Sontheimer RD. Subacute cutaneous lupus
4῏ “”•– —˜™š› K”œ kžŸ‰
erythematosus. Med Clin N Am, 1989; 73:
¡¢£ ¤T¥¦› §¨©¢ Y3Z[
1073ῑ1090
7